Hazard
1,563 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 1,563 cgmp deviation recalls we have scored against our rubric, 1 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 288 (18%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all cgmp deviation recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
VitaminAlly Liposomal Kids Liquid Multivitamin Drops are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Womens 50+ Liquid Multivitamin Drops are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal D3+B12 Spray is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Women's Liquid Multivitamin Drops, iron free, are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly FulviLife Complex oral liquid is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Mens 50+ Liquid Multivitamin Drops are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Joint Nourish oral liquid is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen contamination and possible C. botulinum concerns.
VitaminAlly Liposomal Collagen Booster is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Mens Liquid Multivitamin Drops are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Prenatal+Postnatal Liquid Multivitamin Drops, iron free, are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal D3-5000IU Spray is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Women's Liquid Multivitamin Drops with Iron are being recalled over cGMP deviations that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal B12 Spray is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
VitaminAlly Liposomal Sleep Spray is being recalled over deviations from current Good Manufacturing Practices that could lead to bacterial pathogen and possible C. botulinum concerns.
Wells Pharma is recalling fentanyl citrate injectable solution (1000 mcg/100 mL, 10 mcg per mL) distributed nationwide due to current good manufacturing practice (cGMP) deviations. The recall affects 4,030 IV bags with various lot numbers and expiration dates between April and June 2026.
Wells Pharma of Houston is voluntarily recalling 2,940 IV bags of fentanyl citrate injectable solution due to cGMP (current good manufacturing practice) deviations. The product was distributed nationwide.
Wells Pharma of Houston LLC is recalling 4,975 syringes of Ketamine Hydrochloride Injectable Solution (50 mg/mL) distributed nationwide due to current Good Manufacturing Practice (cGMP) deviations.
Thea Pharma, Inc. is recalling Similasan iVIZIA Sterile Lubricant Eye Drops due to the lack of assurance of sterility caused by manufacturing deviations found by the FDA.
Wells Pharma of Houston LLC is recalling Phenylephrine Hydrochloride Injectable Solution, 40 mg, 250 mL IV bags nationwide due to cGMP deviations. The recall affects 13,070 IV bags with multiple lot numbers and expiration dates through July 2026.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 90 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 63,192 bottles are affected.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 30 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 113,336 bottles are affected.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 60 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 96,096 bottles are affected.
Teva is recalling two lots of Clonidine Transdermal System, USP, 0.2 mg/day, citing CGMP deviations involving the use of an unapproved raw material. 62,136 cartons are affected.
Teva is recalling three lots of Clonidine Transdermal System, USP, 0.3 mg/day, citing CGMP deviations involving the use of an unapproved raw material. 113,943 cartons are affected.
Teva is recalling two lots of Clonidine Transdermal System, USP, 0.1 mg/day, citing CGMP deviations involving the use of an unapproved raw material. 124,054 cartons are affected.